[1]
Bigge, S. 2026. Low-dose oral tranexamic acid for melasma: a narrative review and practical thromboembolic risk assessment framework. International Journal of Research in Dermatology. 12, 5 (Jul. 2026), 525–532. DOI:https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20262368.